Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
QIFENG
873169
5
LAISAI LASER
871263
US OptionsDetailed Quotes
BNTC250516P2500
- 0.00
- 0.000.00%
15min DelayClose May 9 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV81.66%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma3.03Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Benitec Biopharma Newsroom
Benitec Biopharma Is Maintained at Market Outperform by JMP Securities
JMP Securities Maintains Benitec Biopharma(BNTC.US) With Buy Rating, Raises Target Price to $20
Piper Sandler Maintains Benitec Biopharma(BNTC.US) With Buy Rating, Maintains Target Price $30
H.C. Wainwright Maintains Benitec Biopharma(BNTC.US) With Buy Rating, Maintains Target Price $28
Benitec Biopharma Price Target Maintained With a $28.00/Share by HC Wainwright & Co.
Benitec Biopharma Analyst Ratings
Promising Phase 1/2 Trial Results of BB-301 Support Buy Rating for Benitec Biopharma
Piper Sandler Maintains Benitec Biopharma(BNTC.US) With Buy Rating, Maintains Target Price $30
JMP Securities Maintains Benitec Biopharma(BNTC.US) With Buy Rating, Maintains Target Price $18
Piper Sandler Maintains Benitec Biopharma(BNTC.US) With Buy Rating, Maintains Target Price $30
Benitec Biopharma Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Evolent Health (EVH), Benitec Biopharma (BNTC) and Ardelyx (ARDX)
H.C. Wainwright Maintains Benitec Biopharma(BNTC.US) With Buy Rating, Maintains Target Price $28
JMP Securities Maintains Benitec Biopharma(BNTC.US) With Buy Rating, Maintains Target Price $18
Analysts Are Bullish on These Healthcare Stocks: Benitec Biopharma (BNTC), Halozyme (HALO)
H.C. Wainwright Initiates Benitec Biopharma(BNTC.US) With Buy Rating, Announces Target Price $28
HC Wainwright Initiates Benitec Biopharma at Buy With $28 Price Target
Baird Initiates Coverage On Benitec Biopharma With Outperform Rating, Announces Price Target of $30
Baird Initiates Benitec Biopharma(BNTC.US) With Buy Rating, Announces Target Price $30
Benitec Biopharma Price Target Maintained With a $17.00/Share by Guggenheim
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now